Casey Cunningham

Directeur/Membre du Conseil chez Lyric Pharmaceuticals, Inc.

Profil

Casey joined Santé Ventures in 2008 as Chief Scientific Officer and concentrates on the biotechnology space.
Before joining Santé, Casey had a long academic career, first as a faculty member at Harvard Medical School and then as the Associate Director of the Mary Crowley Cancer Research Center, an early phase clinical trial institute with an emphasis on gene and cell-based therapies.
He serves on numerous Advisory Boards, including MD Anderson, The City of Hope, and Baylor Medical School.
Casey is also on the National Board of the Leukemia and Lymphoma Society, where he chairs the Therapy Acceleration Program.
He has played operating roles in several Santé portfolio companies, acting as Chief Medical Officer.
Casey attended fellowship training in oncology and hematology at Massachusetts General Hospital after an internal medicine residency at the Medical College of Wisconsin, where he was also Chief Medical Resident.
He earned his MD from the University of Texas Southwestern Medical School and his BS in physics and biology from Texas A&M.

Postes actifs de Casey Cunningham

Sociétés	Poste	Début
Lyric Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
Nirogy Therapeutics, Inc.	Directeur/Membre du Conseil	-
SHVMS, LLC	Private Equity Investor	01/01/2008

Anciens postes connus de Casey Cunningham

Sociétés	Poste	Fin
Terapio Corp.	Directeur Général	-
AbVitro LLC	Directeur/Membre du Conseil	-
Molecular Templates, Inc. /Old/	Directeur Technique/Scientifique/R&D	25/02/2014

Formation de Casey Cunningham

The University of Texas at Austin	Undergraduate Degree
The University of Texas Southwestern Medical Center	Doctorate Degree